| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |